|
|
|
|
Expression of Rho GDI in rat osteoblasts intermittently exposed to parathyroid hormone in vitro and in vivo
The proteomics analysis indicated that a total of 26 proteins were up- or down-regulated in the Itm group compared with the Ctr group at 6 h and 24 h; among these, 15 proteins were successfully identified.These proteins mainly belong to...
|
|
|
Dr. Gott: Shingles could be sign of cancer
s storyCommentsShare Dear Dr.Gott: I just wanted to write to thank you for saving my life. Quite some time ago, you had an article that stated that if a person suffers from repeated attacks of shingles, the cause may really be a...
|
|
|
Parathyroid Incidentalomas Detected on Routine Ultrasound-Directed Fine-Needle Aspiration Biopsy in Patients R
Save in My Library Free Abstract Kwak JY et al.- The prevalence of parathyroid incidentaloma was 0.4% in a large series of patients referred for suspected thyroid nodules. The use of FNA-PTH combined with FNAB can help clinicians...
|
|
|
[Breast Cancer] Secondary Causes of Low Bone Mass in Patients With Breast Cancer: A Need for Greater Vigilance
From Royal Melbourne Hospital; Royal Women's Hospital; University of Melbourne; Western Hospital; and Centre for Research Excellence in Patient Safety, Monash University, Melbourne, Australia.* To whom correspondence should be addressed....
|
|
|
Serum and stimulated whole saliva parathyroid hormone in menopausal women with oral dry feeling
stimulated whole saliva PTH, and with saliva calcium levels in this group of menopausal women.Thus, salivary calcium and PTH levels appear associated with OD and menopause. Today in ... Serum and stimulated whole saliva parathyroid...
|
|
|
Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3.Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. Utility of...
|
|
|
Endocrine Society Announces 2009 Laureate Award Winners
The Endocrine Society is pleased to announce the 2009 Laureate Awards established in 1944 to recognize the highest achievements in endocrinology including: science, leadership, teaching and service.This year's Laureate Awards were...
|
|
|
Yissum introduces novel compound to treat osteoporosis
Yissum Research Development Company Ltd, the technology transfer company of the Hebrew University of Jerusalem, introduced a new compound for the treatment of osteoporosis.The new potential therapeutic was presented by professor Itai Bab...
|
|
|
Parathyroid Hormone Levels Provide Clue to Outcomes in Elderly Hip Breaks
_ Parathyroid Hormone Levels Provide Clue to Outcomes in Elderly Hip Breaks.
|
|
|
Parathyroid Hormone Levels Provide Clue to Outcomes in Elderly Hip Breaks
_ Parathyroid Hormone Levels Provide Clue to Outcomes in Elderly Hip Breaks.
|
|
|
Researchers from Kaiser Permanente detail findings in hyperparathyroidism
Scientists discuss in 'Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes' new findings in hyperparathyroidism.According to recent research from the United States, 'Hyperparathyroidism may...
|
|
|
NPS Pharmaceuticals to Present at Jefferies Healthcare Conference
BEDMINSTER, N.J.- (BUSINESS WIRE) - NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the Jefferies 3rd Annual Healthcare Conference in...
|
|
|
MDRNA Wins FDA OK for Calcitonin in Osteo
By Catherine Hollingsworth Staff Writer MDRNA Inc.is making good on its plan to maximize its shelved nasal programs, with the FDA's approval of a generic nasal spray for osteoporosis that has been launched by Par Pharmaceutical Cos. The...
|
|
|
NPS Pharmaceuticals to Present at Needham Life Sciences Conference
- NPS Pharmaceuticals, Inc.(Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the 8th Annual Needham Life Sciences Conference in New York on Thursday, June 11, 2009...
|
|
|
CapIMAGE Gamma Camera Designed for Small Organs, Cardio
Capintecs CapIMAGE is a small field of view gamma camera system designed for static, dynamic and gated imaging of small organs and body parts including thyroid, parathyroid, bone, selected lymphoscintigraphy and gated cardiac studies....
|
|
|
Yissum Introduces Novel Compound for the Treatment of Osteoporosis
- Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, introduced today a new compound for the treatment of osteoporosis.The new potential therapeutic will be presented by...
|
|
|
Yissum Introduces Novel Compound for the Treatment of Osteoporosis
Professors Itai Bab and Raphael Mechoulam, from the School of Pharmacy at the Hebrew University of Jerusalem, invented a new drug candidate for the treatment of osteoporosis that both inhibits bone resorption and stimulates bone formation.
|
|
|
Novocell Obtains U.S. Patent for Drug Screening Human Embryonic Cell Derived-Endoderm Cells
Patent Covers Methods for Identifying Endoderm Differentiation Factors SAN DIEGO--(BUSINESS WIRE)--Jun 3, 2009 - Novocell, Inc., a stem cell engineering company, today announced that it has received U.S.Patent No. 7,541,185 with method...
|
|
|
Factors regulating circulating vascular endothelial growth factor (VEGF): Association with bone mineral densit
Positive correlations were seen between circulating VEGF and BMI and oestradiol Serum VEGF was associated with the G(634) polymorphism and dietary calcium intake In vitro studies: association with calcium intake could be mediated by ...
|
|
|
Kuros completes patient recruitment in a Phase IIb trial of KUR-111 in patients with tibial plateau fractures
- Kuros Biosurgery AG announced that it has completed patient recruitment in a Phase IIb clinical trial designed to assess the efficacy and safety of KUR-111 (Viz.I-0401) in tibial plateau fractures. The aim of the trial is to assess...
|
|
|
Kuros Completes Patient Recruitment in Phase IIb Trial of KUR-111 in Patients with Tibial Plateau Fractures
Study comparing KUR-111 to autologous bone grafting expected to report in Q1 2010 Zurich, Switzerland, 8 June 2009 - Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial...
|
|
|
UPDATE 1-Goldman ups NPS Pharmaceuticals to neutral, shares rise
June 8 (Reuters) - Goldman Sachs removed NPS Pharmaceuticals from its Americas sell list and raised the stock to 'neutral' on valuation.'NPS Pharmaceuticals ( NPSP - news - people ) is down 43 percent year-to-date, falling below our...
|
|
|
NPS Pharmaceuticals to Present at Needham Life Sciences Conference
BEDMINSTER, N.J.- (BUSINESS WIRE) - NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the 8th Annual Needham Life Sciences Conference in...
|
|
|
NPS Pharmaceuticals to Present at Needham Life Sciences Conference
- NPS Pharmaceuticals, Inc.(Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the 8th Annual Needham Life Sciences Conference in New York on Thursday, June 11, 2009...
|
|
|
NPS Pharmaceuticals to Present at Needham Life Sciences Conference
NPS Pharmaceuticals, Inc.( NASDAQ:NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the 8th Annual Needham Life Sciences Conference in New York on Thursday, June 11, 2009 at...
|
